Maria's record says two pregnancies. It misses severe preeclampsia and delivery at thirty-one weeks. Record those details and verify the history when possible. They matter to today's prevention discussion, but they do not establish that Maria already has atherosclerotic cardiovascular disease.

Build the current assessment. Review blood pressure, the lipid profile, family history, actual medicines and patient preferences. Lipoprotein little a contributes inherited-risk information; it is not a measurement of arterial blockage. The current guideline uses PREVENT for primary prevention. Obtain the required inputs before calculating risk. Do not invent a score from this abbreviated case.

Now consider the separate pregnancy-planning branch. Review the exact medicine, why it is prescribed, and the patient's pregnancy and feeding plans. The Food and Drug Administration advises stopping statins in most pregnant patients, while allowing individualized decisions for those at very high cardiovascular risk. If ongoing statin treatment is needed after delivery, breastfeeding is not recommended. Coordinate these decisions with the prescriber and relevant specialists.

For Maria, agree on the next prevention decision after completing the assessment. Explain what the pregnancy history and lipid findings mean without predicting an inevitable heart attack. Name who will follow up and when.